Scroll
To Top
0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

*Important

The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.


Solve ME/CFS Initiative


Address

5455 Wilshire Blvd. Ste 1903
Los Angeles, CA 90036 USA

Phone

704-364-0016

Fax

7043659755

800 Number

8004423437

Email Address

SolveCFS@SolveCFS.org

Description

The Solve ME/CFS Initiative (SMCI) is committed to making Myalgic Encephalomyelitis (ME) and Chronic Fatigue Syndrome (CFS) understood, diagnosable, and treatable. We are the leading disease organization solely dedicated to solving ME/CFS. We believe the best way to serve patients is to defeat this disease by investing in promising research and advocating for increased federal funding to support scientific discovery.

Facebook: http://facebook.com/SolveMECFSInitiative
Twitter: http://@plzsolvecfs

Please Note

The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and the credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions is strictly prohibited.

NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.